Literature DB >> 21640505

Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.

Vitali Moiseenko1, Jonn Wu, Allan Hovan, Ziad Saleh, Aditya Apte, Joseph O Deasy, Stephen Harrow, Carman Rabuka, Adam Muggli, Anna Thompson.   

Abstract

PURPOSE: The severe reduction of salivary function (xerostomia) is a common complication after radiation therapy for head-and-neck cancer. Consequently, guidelines to ensure adequate function based on parotid gland tolerance dose-volume parameters have been suggested by the QUANTEC group and by Ortholan et al. We perform a validation test of these guidelines against a prospectively collected dataset and compared with a previously published dataset. METHODS AND MATERIALS: Whole-mouth stimulated salivary flow data from 66 head-and-neck cancer patients treated with radiotherapy at the British Columbia Cancer Agency (BCCA) were measured, and treatment planning data were abstracted. Flow measurements were collected from 50 patients at 3 months, and 60 patients at 12-month follow-up. Previously published data from a second institution, Washington University in St. Louis (WUSTL), were used for comparison. A logistic model was used to describe the incidence of Grade 4 xerostomia as a function of the mean dose of the spared parotid gland. The rate of correctly predicting the lack of xerostomia (negative predictive value [NPV]) was computed for both the QUANTEC constraints and Ortholan et al. recommendation to constrain the total volume of both glands receiving more than 40 Gy to less than 33%.
RESULTS: Both datasets showed a rate of xerostomia of less than 20% when the mean dose to the least-irradiated parotid gland is kept to less than 20 Gy. Logistic model parameters for the incidence of xerostomia at 12 months after therapy, based on the least-irradiated gland, were D(50) = 32.4 Gy and and γ = 0.97. NPVs for QUANTEC guideline were 94% (BCCA data), and 90% (WUSTL data). For Ortholan et al. guideline NPVs were 85% (BCCA) and 86% (WUSTL).
CONCLUSION: These data confirm that the QUANTEC guideline effectively avoids xerostomia, and this is somewhat more effective than constraints on the volume receiving more than 40 Gy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21640505      PMCID: PMC3192313          DOI: 10.1016/j.ijrobp.2011.04.020

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

2.  Submandibular salivary gland transfer prevents radiation-induced xerostomia.

Authors:  N Jha; H Seikaly; T McGaw; L Coulter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-01       Impact factor: 7.038

3.  CERR: a computational environment for radiotherapy research.

Authors:  Joseph O Deasy; Angel I Blanco; Vanessa H Clark
Journal:  Med Phys       Date:  2003-05       Impact factor: 4.071

4.  A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.

Authors:  Judith M Roesink; Maria Schipper; Wim Busschers; Cornelis P J Raaijmakers; Chris H J Terhaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-06-20       Impact factor: 7.038

5.  Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.

Authors:  Marc W Münter; Simone Hoffner; Holger Hof; Klaus K Herfarth; Uwe Haberkorn; Volker Rudat; Peter Huber; Jürgen Debus; Christian P Karger
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-15       Impact factor: 7.038

Review 6.  Quantifying the position and steepness of radiation dose-response curves.

Authors:  S M Bentzen; S L Tucker
Journal:  Int J Radiat Biol       Date:  1997-05       Impact factor: 2.694

7.  Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.

Authors:  Angel I Blanco; K S Clifford Chao; Issam El Naqa; Gregg E Franklin; Konstantin Zakarian; Milos Vicic; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

8.  A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.

Authors:  K S Chao; J O Deasy; J Markman; J Haynie; C A Perez; J A Purdy; D A Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

9.  The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data.

Authors:  S A Roberts; J H Hendry
Journal:  Radiother Oncol       Date:  1993-10       Impact factor: 6.280

10.  A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.

Authors:  Antonetta C Houweling; Marielle E P Philippens; Tim Dijkema; Judith M Roesink; Chris H J Terhaard; Cornelis Schilstra; Randall K Ten Haken; Avraham Eisbruch; Cornelis P J Raaijmakers
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-12-16       Impact factor: 7.038

View more
  23 in total

Review 1.  Revisiting the dose constraints for head and neck OARs in the current era of IMRT.

Authors:  N Patrik Brodin; Wolfgang A Tomé
Journal:  Oral Oncol       Date:  2018-09-08       Impact factor: 5.337

2.  Incorporating single-side sparing in models for predicting parotid dose sparing in head and neck IMRT.

Authors:  Lulin Yuan; Q Jackie Wu; Fang-Fang Yin; Yuliang Jiang; David Yoo; Yaorong Ge
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

3.  Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.

Authors:  Maria Thor; Adepitan A Owosho; Haley D Clark; Jung Hun Oh; Nadeem Riaz; Allan Hovan; Jillian Tsai; Steven D Thomas; Sae Hee K Yom; Jonn S Wu; Joseph M Huryn; Vitali Moiseenko; Nancy Y Lee; Cherry L Estilo; Joseph O Deasy
Journal:  Radiother Oncol       Date:  2016-11-24       Impact factor: 6.280

Review 4.  Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician.

Authors:  Jolien Heukelom; Clifton David Fuller
Journal:  Semin Radiat Oncol       Date:  2019-07       Impact factor: 5.934

5.  A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.

Authors:  N Patrik Brodin; Rafi Kabarriti; Mark Pankuch; Clyde B Schechter; Vinai Gondi; Shalom Kalnicki; Chandan Guha; Madhur K Garg; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-26       Impact factor: 7.038

6.  Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.

Authors:  Peter van Luijk; Sarah Pringle; Joseph O Deasy; Vitali V Moiseenko; Hette Faber; Allan Hovan; Mirjam Baanstra; Hans P van der Laan; Roel G J Kierkels; Arjen van der Schaaf; Max J Witjes; Jacobus M Schippers; Sytze Brandenburg; Johannes A Langendijk; Jonn Wu; Robert P Coppes
Journal:  Sci Transl Med       Date:  2015-09-16       Impact factor: 17.956

7.  Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.

Authors:  N Patrik Brodin; Rafi Kabarriti; Madhur K Garg; Chandan Guha; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-29       Impact factor: 7.038

8.  A case of cervical multicentric Castleman disease treated with intensity-modulated radiation therapy using helical tomotherapy.

Authors:  Natsuo Tomita; Takeshi Kodaira; Takuya Tomoda; Kosei Nakajima; Takayuki Murao; Kunio Kitamura
Journal:  Jpn J Radiol       Date:  2012-01-19       Impact factor: 2.374

9.  Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.

Authors:  Klaudia U Hunter; Laura L Fernandes; Karen A Vineberg; Daniel McShan; Alan E Antonuk; Craig Cornwall; Mary Feng; Mathew J Schipper; James M Balter; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-09-10       Impact factor: 7.038

10.  Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors.

Authors:  Puja Aggarwal; Katherine A Hutcheson; Adam S Garden; Frank E Mott; Charles Lu; Ryan P Goepfert; Clifton D Fuller; Stephen Y Lai; G Brandon Gunn; Mark S Chambers; Erich M Sturgis; Ehab Y Hanna; Sanjay Shete
Journal:  Cancer       Date:  2021-08-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.